SCHEMBL30400992

SCHEMBL30400992

CC(C)(C)OC(=O)N1CCC2(CC1)CC(=O)c1ccc(B3OC(C)(C)C(C)(C)O3)cc12

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 2/20 0.44
▸ PRMT5 O14744 1/20 0.40
▸ WDR77 Q9BQA1 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ BACE2 Q9Y5Z0 1/20 0.40
▸ BUB1 O43683 1/20 0.38
▸ PDK2 Q15119 1/20 0.37
▸ GPR119 Q8TDV5 3/20 0.36
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC8 Q9BY41 2/20 0.36
▸ HDAC6 Q9UBN7 2/20 0.36
▸ AAK1 Q2M2I8 1/20 0.35
▸ HRH3 Q9Y5N1 3/20 0.35
▸ ALK Q9UM73 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26176373 1.00 USP30 (0.44) USP30PRMT5WDR77BACE1BACE2
SCHEMBL29964244 0.80 KMT2A (0.52) USP30GPR119HDAC1HDAC8HDAC6
SCHEMBL742173 0.80 KMT2A (0.52) USP30GPR119HDAC1HDAC8HDAC6
SCHEMBL26023997 0.80 USP30 (0.44) USP30PRMT5WDR77BACE1BACE2
SCHEMBL31693862 0.80 HDAC2 (0.43) USP30BUB1PDK2GPR119HDAC1
SCHEMBL31694099 0.80 ALK (0.42) USP30BACE1BUB1PDK2GPR119
SCHEMBL2187569 0.80 MEN1 (0.46) USP30BUB1PDK2GPR119HDAC1
SCHEMBL30623425 0.80 MEN1 (0.46) USP30BUB1PDK2GPR119HDAC1
SCHEMBL26176388 0.80 ALK (0.42) USP30BACE1BUB1PDK2GPR119
SCHEMBL30935054 0.78 USP30 (0.41) USP30PRMT5WDR77BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP disclosed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO disclosed
Send feedback